Antibody and Safety Study of 6 Doses of NicVAX in Smokers
Clinical trial NCT00598325 · COMPLETED
Trial details
- NCT number
- NCT00598325
- Sponsor
- Nabi Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-10-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.